Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: Toxicological implications

Journal of Ethnopharmacology

Volumn 166, Issue , 2015, Pages 250-260

  Yamani, Amal ^a,b   Bunel, Valérian ^a   Antoine, Marie Hélène ^a   Husson, Cécile ^a   Stévigny, Caroline ^a   Duez, Pierre ^a,c   Elachouri, Mostafa ^b   Nortier, Joëlle ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b FACULTÉ DES SCIENCES   (Morocco)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

Aristolochiabaetica L.; Aristolochialonga L.; Bryonia dioica Jacq.; HK 2cells; Misidentification; Toxicity

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; ADVERSE DRUG REACTION; ALPHA SMOOTH MUSCLE ACTIN; ARISTOLOCHIA LONGA EXTRACT; ARISTOLOCHIC ACID; ARTISTOLOCHIA BAETICA EXTRACT; BETA CATENIN; BRYONIA DIOICA EXTRACT; CADHERIN; FIBRONECTIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; PLANT EXTRACT; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADVERSE EFFECTS; ARISTOLOCHIA; ARISTOLOCHIA BAETICA; ARISTOLOCHIA LONGA; ARTICLE; BRYONIA; BRYONIA DIOICA; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECTS; ETHNOPHARMACOLOGY; HERB; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY; KIDNEY DISEASE; KIDNEY TUBULE CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINAL PLANT; METABOLISM; MOROCCO; NEPHROTOXICITY; NONHUMAN; PATIENT SAFETY; PHYTOTOXICITY; PROCEDURES; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIN LAYER CHROMATOGRAPHY; TRADITIONAL HEALER; TRADITIONAL MEDICINE; UPREGULATION;

ACTINS; ADVERSE EFFECTS; ARISTOLOCHIA; BETA CATENIN; BRYONIA; CADHERINS; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; DOWN-REGULATION; DRUG EFFECTS; ETHNOPHARMACOLOGY; FIBRONECTINS; HUMANS; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; METABOLISM; METHODS; MOROCCO; PLANT EXTRACTS; PLANTS, MEDICINAL; UP-REGULATION;

ARISTOLOCHIA; ARISTOLOCHIA BAETICA; BRYONIA; BRYONIA DIOICA;

EID: 84964240847     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.03.036     Document Type: Article

References (54)

1. J. Bellakhdar La Pharmacopée Marocaine Traditionnelle 1999 Ibis Press Paris
2. J. Bellakhdar, R. Claisse, J. Fleurentin, and C. Younos Repertory of standard herbal drugs in the Moroccan pharmacopoea J. Ethnopharmacol. 35 1991 123 143
3. M. Bnouham, F.M. Merhfour, M. Elachoui, A. Legssyer, H. Mekhfi, D. Lamnaouer, and A. Ziyyat Toxic effects of some medicinal plants used in Moroccan traditional medicine J. Biol. 2 2006 21 30
4. J. Boustie, A. Caubet, and M. Paris Atlas des intoxications dorigine végétale 2002 Encycl Méd Chir Paris
5. Bruneton, J.; 1996. Plantes toxiques: Végétaux dangereux pour l′homme et les animaux, third ed, Paris.
6. Bulletin Officiel, 1923. Résidence Générale de France à Rabat.
7. V. Bunel, M.H. Antoine, J. Nortier, P. Duez, and C. Stevigny Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro J. Appl. Toxicol. 34 2014 1311 1319
8. V. Bunel, M. Ouedraogo, A.T. Nguyen, C. Stévigny, and P. Duez Methods applied to the in vitro primary toxicology testing of natural products: state of the art, strengths, and limits Planta Med. 80 2014 1210 1226
9. CAPM - Centre Anti-Poison du Maroc, 2010. Toxicologie Maroc. In: Ministère de la Santé (Ed.), Annual Report, Société Empreintes Edition ed.
10. W. Chan, Y. Zheng, and Z. Cai Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids J. Am. Soc. Mass Spectrom. 18 2007 642 650
11. D. Chen, Z. Tang, C. Luo, H. Chen, and Z. Liu Clinical and pathological spectrums of aristolochic acid nephropathy Clin. Nephrol. 78 2012 54 60
12. Council of Europe European Pharmacopoeia eighth ed. 2013 Tec & Doc Strasbourg
13. F.D. Debelle, J.L. Vanherweghem, and J.L. Nortier Aristolochic acid nephropathy: a worldwide problem Kidney Int. 74 2008 158 169
14. M. Eddouks, M. Maghrani, A. Lemhadri, M.L. Ouahidi, and H. Jouad Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet) J. Ethnopharmacol. 82 2002 97 103
15. J. El-Hilaly, M. Hmammouchi, and B. Lyoussi Ethnobotanical studies and economic evaluation of medicinal plants in Taounate province (Northern Morocco) J. Ethnopharmacol. 86 2003 149 158
16. J. Fakchich, and M. Elachouri Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments J. Ethnopharmacol. 154 2014 76 87
17. M. Fennae, M. Ibn Tattou, J. Mathez, A. Ouyahya, J. El Oualidi, and P. Quezel Flore Pratique du Maroc: Manuel de Determination des Plantes Vasculaires 1999 Insitut Scientifique de Rabat Rabat
18. M.R. Gokmen, J.P. Cosyns, V.M. Arlt, M. Stiborova, D.H. Phillips, H.H. Schmeiser, M.S. Simmonds, H.T. Cook, J.L. Vanherweghem, J.L. Nortier, and G.M. Lord The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review Ann. Intern. Med. 158 2013 469 477
19. M. Heinrich, J. Chan, S. Wanke, C. Neinhuis, and M.S. Simmonds Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2 - A global assessment based on bibliographic sources J. Ethnopharmacol. 125 2009 108 144
20. Hmamouchi, M.; 1997. Plantes alimentaires, aromatiques, condimentaires, médicinales et toxiques au Maroc. 23, 89-108.
21. R.J. Huxtable The harmful potential of herbal and other plant products Drug Saf. 5 Suppl 1 1990 S126 S136
22. H. Jouad, M. Haloui, H. Rhiouani, J. El Hilaly, and M. Eddouks Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco (Fez-Boulemane) J. Ethnopharmacol. 77 2001 175 182
23. F.Z. Kabbaj, B. Meddah, Y. Cherrah, and M.E.A. Faouzi Ethnopharmacological profile of traditional plants used in Morocco by cancer patients as herbal therapeutics Phytopharmacology 2 2012 243 256
24. W. Kriz, B. Kaissling, and M. Le Hir Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121 2011 468 474
25. M. Larhsini Biological and toxicological properties of Moroccan plant extracts: advances in research F.A.a.M.O. Iqbal Ahmad, Modern phytomedicine: turning medicinal plants into drugs 2006 Wiley Weinheim 123 136
26. C. Lebeau, V.M. Arlt, H.H. Schmeiser, A. Boom, P.J. Verroust, O. Devuyst, and R. Beauwens Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells Kidney Int. 60 2001 1332 1342
27. C. Lebeau, F.D. Debelle, V.M. Arlt, A. Pozdzik, E.G. De Prez, D.H. Phillips, M.M. Deschodt-Lanckman, J.L. Vanherweghem, and J.L. Nortier Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies Nephrol. Dial. Transplant. 20 2005 2321 2332
28. S.B. Lee, and R. Kalluri Mechanistic connection between inflammation and fibrosis Kidney Int. 78 2010 S22 26
29. J. Li, L. Zhang, Z. Jiang, B. Shu, F. Li, and Q. Bao Toxicities of aristolochic acid I and aristololactam I in cultured renal epithelial cells Toxicol. In Vitro 24 2010 1092 1097
30. A. Merzouki, F. Ed-derfoufi, and J. Molero Mesa Contribution to the knowledge of Rifian traditional medicine. II: folk medicine in Ksar Lakbir district (NW Morocco) Fitoterapia 71 2000 278 307
31. J. Michl, M.J. Ingrouille, M.S. Simmonds, and M. Heinrich Naturally occurring aristolochic acid analogues and their toxicities Nat. Prod. Rep. 31 2014 676 693
32. J. Michl, H.M. Jennings, G.C. Kite, M.J. Ingrouille, M.S.J. Simmonds, and M. Heinrich Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach J. Ethnopharmacol. 149 2013 235 244
33. S.M. Munoz, S.M. Salvarelli, M.I. Saiz, and F.P. Conde A toxic protein from Bryonia dioica Jacq. fruits: the brydiofin Biochem. Biophys. Res. Commun. 183 1992 1011 1018
34. J.L. Nortier, M.C. Martinez, H.H. Schmeiser, V.M. Arlt, C.A. Bieler, M. Petein, M.F. Depierreux, L. De Pauw, D. Abramowicz, P. Vereerstraeten, and J.L. Vanherweghem Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) New Engl. J. Med. 342 2000 1686 1692
35. A. Ouarghidi, G.J. Martin, B. Powell, G. Esser, and A. Abbad Botanical identification of medicinal roots collected and traded in Morocco and comparison to the existing literature J. Ethnobiol. Ethnomed. 9 2013 59
36. A. Ouarghidi, B. Powell, G.J. Martin, H. de Boer, and A. Abbad Species substitution in medicinal roots and possible implications for toxicity of herbal remedies in Morocco Econ. Botany 66 2012 370 382
37. A. Panossian, E. Gabrielian, and H. Wagner Plant adaptogens. II. Bryonia as an adaptogen Phytomedicine 4 1997 85 99
38. J. Pohlmann Die cucurbitacine in Bryonia alba und Bryonia dioica Phytochemistry 14 1975 1587 1589
39. A.A. Pozdzik, I.J. Salmon, F.D. Debelle, C. Decaestecker, C. Van den Branden, D. Verbeelen, M.M. Deschodt-Lanckman, J.L. Vanherweghem, and J.L. Nortier Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation Kidney Int. 73 2008 595 607
40. F.-X. Reichl Guide Pratique de Toxicologie second ed. 2002 de Boeck Brussels
41. D. Shaw, G. Ladds, P. Duez, E. Williamson, and K. Chan Pharmacovigilance of herbal medicine J. Ethnopharmacol. 140 2012 513 518
42. Skalli, S.; 2010. Bereztem - Grande menace pour la santé dun produit dit 'naturel', Toxicologie Maroc.
43. A. Tahraoui, J. El-Hilaly, Z.H. Israili, and B. Lyoussi Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province) J. Ethnopharmacol. 110 2007 105 117
44. I. Tazi, H. Nafil, and L. Mahmal Fatal renal failure due to self administration of Aristolochia longa after treatment with chemotherapy Arab J. Nephrol. Transplant 5 2012 54 discussion 55
45. M. Valcu, and C.M. Valcu Data transformation practices in biomedical sciences Nat. Methods 8 2011 104 105
46. J.-L. Vanherweghem, F. Debelle, M.-C. Muniz-Martinez, and J. Nortier Aristolochic acid nephropathy after Chinese herbal remedies M. de Broe, G. Porter, W. Bennett, G. Verpooten, Clinical Nephrotoxins 2003 Springer Netherlands 579 586
47. J.L. Vanherweghem, M. Depierreux, C. Tielemans, D. Abramowicz, M. Dratwa, M. Jadoul, C. Richard, D. Vandervelde, D. Verbeelen, and R. Vanhaelen-Fastre Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs Lancet 341 1993 387 391
48. WHO, 2012. A Review of Human Carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans, Geneva, pp. 1-486.
49. World Medical Association, 2008. Declaration of Helsinki, consulted on 14th november 2012.
50. K.M. Wu, J.G. Farrelly, R. Upton, and J. Chen Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development Phytomedicine 14 2007 273 279
51. T.A. Wynn Fibrosis under arrest Nat. Med. 16 2010 523 525
52. J. Yuan, Q. Liu, G. Wei, F. Tang, L. Ding, and S. Yao Characterization and determination of six aristolochic acids and three aristololactams in medicinal plants and their preparations by high-performance liquid chromatography-photodiode array detection/electrospray ionization mass spectrometry Rapid Commun. Mass Spectrom. 21 2007 2332 2342
53. A.A. Zeggwagh, Y. Lahlou, and Y. Bousliman Survey of toxicological aspects of herbal medicine used by a herbalist in Fes Morocco Pan Afr. Med. J. 14 2013 125
54. L. Zhang, J. Yan, X. Liu, Z. Ye, X. Yang, R. Meyboom, K. Chan, D. Shaw, and P. Duez Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective J. Ethnopharmacol. 140 2012 519 525